Researchers develop test that predicts severe immune reaction to biologics A test that uses cells from a single donor’s blood to predict whether a new drug will cause a severe immune reaction in humans has been developed by researchers at Imperial College London.…
AstraZeneca spins out early-stage R&D for antibiotic compoundsAstraZeneca is creating a standalone subsidiary to work exclusively on early-stage antibiotics research and development, the company has announced.…
Malaria eradication: blocking transmission to mosquitoes To wipe out malaria, researchers are racing to develop a vaccine that protects mosquitoes from infection.…
Ebola clinical trial suspended after volunteers complain of joint pains A phase I clinical trial of the fast-tracked Ebola vaccine VSV-ZEBOV has been halted in Switzerland because some trial participants developed mild joint pain.…
Phase I trial of GlaxoSmithKline’s Ebola vaccine shows it is well tolerated No major adverse events were reported in an Ebola vaccine phase I trial involving 20 volunteers.…
Immune checkpoint inhibitors bring new hope to cancer patients PD-1 and PD-L1 inhibitors induce a higher response rate across a wider range of tumours than other immunotherapies.…
Q&A: Ensuring vaccine safety is no easy task Patrick LF Zuber, group leader for global vaccine safety at the World Health Organization, talks about vaccine safety, the Ebola vaccine and new vaccines in the pipeline.…
